Dopaminergic Therapy for Restless Legs Syndrome/Willis-Ekbom Disease.
Dopaminergic therapies have been a mainstay of restless legs treatment and are endorsed as first-line therapies by multiple professional societies. This article summarizes the differences and similarities among the dopamine agonists with attention to pharmacology, efficacy, side effects, and dosing.
Sleep Disorders Center, University of California San Francisco, 2330 Post Street, San Francisco, CA 94115, USA. Electronic address: Rochelle.Zak@ucsf.edu.
Rochelle S
RS
Zak
Department of Neurology, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN 37232, USA.
Arthur S
AS
Walters
D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D012148:Restless Legs Syndrome / Q000188:drug therapy*
D018491:Dopamine Agonists
Dopamine agonists; Restless legs syndrome; Treatment efficacy; Willis-Ekbom disease